Manoj Kumar Bhat

3.1k total citations
56 papers, 2.3k citations indexed

About

Manoj Kumar Bhat is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Manoj Kumar Bhat has authored 56 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 20 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Manoj Kumar Bhat's work include Cancer-related Molecular Pathways (13 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer, Lipids, and Metabolism (11 papers). Manoj Kumar Bhat is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer, Lipids, and Metabolism (11 papers). Manoj Kumar Bhat collaborates with scholars based in India, United States and United Kingdom. Manoj Kumar Bhat's co-authors include Balkrishna Chaube, Maleppillil Vavachan Vijayakumar, Parmanand Malvi, Naoshad Mohammad, Shivendra V. Singh, Amrendra K. Ajay, Sandeep Singh, Vimal Pandey, Rishi Raj Chhipa and Pranay Ramteke and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Manoj Kumar Bhat

54 papers receiving 2.3k citations

Peers

Countries citing papers authored by Manoj Kumar Bhat

Since Specialization

Citations

This map shows the geographic impact of Manoj Kumar Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manoj Kumar Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manoj Kumar Bhat more than expected).

Fields of papers citing papers by Manoj Kumar Bhat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manoj Kumar Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manoj Kumar Bhat. The network helps show where Manoj Kumar Bhat may publish in the future.

Co-authorship network of co-authors of Manoj Kumar Bhat

This figure shows the co-authorship network connecting the top 25 collaborators of Manoj Kumar Bhat. A scholar is included among the top collaborators of Manoj Kumar Bhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manoj Kumar Bhat. Manoj Kumar Bhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-tumor response by targeting glucose metabolism and depletion of membrane cholesterol in breast cancer and melanoma cells 2025 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), (unknown), (unknown), Shyamananda Singh Mayengbam, Manoj Kumar Bhat	0
2	An anti-neoplastic tale of metformin through its transport 2024 ·Life Sciences ·(unknown), Manoj Kumar Bhat	0
3	Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells 2023 ·SHILAP Revista de lepidopterología ·Shyamananda Singh Mayengbam, (unknown), (unknown), (unknown), (unknown), Dipti Athavale, Pranay Ramteke, Manoj Kumar Bhat	11
4	Obesity Programs Macrophages to Support Cancer Progression 2022 ·Cancer Research ·(unknown), Shyamananda Singh Mayengbam, (unknown), Mohan R. Wani, Manoj Kumar Bhat	22
5	Influence of cholesterol on cancer progression and therapy 2021 ·Translational Oncology ·Shyamananda Singh Mayengbam, (unknown), Ajay D. Pillai, Manoj Kumar Bhat	98
6	Resistin: A journey from metabolism to cancer 2021 ·Translational Oncology ·(unknown), (unknown), Pranay Ramteke, (unknown), Manoj Kumar Bhat	55
7	Role of TNFα and leptin signaling in colon cancer incidence and tumor growth under obese phenotype 2019 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Snahlata Singh, Shyamananda Singh Mayengbam, Surbhi Chouhan, (unknown), Pranay Ramteke, Dipti Athavale, Manoj Kumar Bhat	18
8	Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state 2018 ·SHILAP Revista de lepidopterología ·Parmanand Malvi, Balkrishna Chaube, Shivendra V. Singh, Naoshad Mohammad, Maleppillil Vavachan Vijayakumar, Snahlata Singh, Surbhi Chouhan, Manoj Kumar Bhat	49
9	Methylglyoxal attenuates insulin signaling and downregulates the enzymes involved in cholesterol biosynthesis 2017 ·Molecular BioSystems ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Manoj Kumar Bhat, Mahesh J. Kulkarni	13
10	AMPK maintains energy homeostasis and survival in cancer cells via regulating p38/PGC-1α-mediated mitochondrial biogenesis 2015 ·Cell Death Discovery ·Balkrishna Chaube, Parmanand Malvi, Shivendra V. Singh, Naoshad Mohammad, Benoı̂t Viollet, Manoj Kumar Bhat	124
11	Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex 2015 ·Scientific Reports ·Naoshad Mohammad, Shivendra V. Singh, Parmanand Malvi, Balkrishna Chaube, Dipti Athavale, Muralidharan Vanuopadath, Sudarslal Sadasivan Nair, Bipin G. Nair, Manoj Kumar Bhat	93
12	Diet‐induced obesity increases melanoma progression: Involvement of Cav‐1 and FASN 2011 ·International Journal of Cancer ·Vimal Pandey, Maleppillil Vavachan Vijayakumar, Amrendra K. Ajay, Parmanand Malvi, Manoj Kumar Bhat	73
13	Hypolipidemic Effect of Fenugreek Seeds Is Mediated Through Inhibition of Fat Accumulation and Upregulation of LDL Receptor 2009 ·Obesity ·Maleppillil Vavachan Vijayakumar, Vimal Pandey, Gyan C. Mishra, Manoj Kumar Bhat	58
14	Atomic force microscopy, biochemical analysis of 3T3-L1 cells differentiated in the absence and presence of insulin 2008 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Vimal Pandey, (unknown), Ruchika Kaul-Ghanekar, (unknown), Kishore M. Paknikar, Manoj Kumar Bhat	4
15	Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data) 2008 ·Current Cancer Drug Targets ·(unknown), Amrendra K. Ajay, Sandeep Singh, Manoj Kumar Bhat	21
16	Abrogation of p53 by its antisense in MCF-7 breast carcinoma cells increases cyclin D1 via activation of Akt and promotion of cell proliferation 2007 ·Experimental Cell Research ·Rishi Raj Chhipa, Ratna Kumari, (unknown), Manoj Kumar Bhat	9
17	Synthesis and evaluation of antifungal properties of a series of the novel 2-amino-5-oxo-4-phenyl-5,6,7,8-tetrahydroquinoline-3-carbonitrile and its analogues 2007 ·Bioorganic & Medicinal Chemistry ·Atul R. Gholap, Kiran S. Toti, Fazal Shirazi, Ratna Kumari, Manoj Kumar Bhat, Mukund V. Deshpande, Kumar V. Srinivasan	115
18	p53 regulates ERK activation in carboplatin induced apoptosis in cervical carcinoma: A novel target of p53 in apoptosis 2006 ·FEBS Letters ·Sandeep Singh, (unknown), Amrendra K. Ajay, Manoj Kumar Bhat	64
19	DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells 2005 ·Cancer Letters ·Sandeep Singh, Rishi Raj Chhipa, Maleppillil Vavachan Vijayakumar, Manoj Kumar Bhat	19
20	Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-κB in human HPV-18 E6-positive HEp-2 cells 2004 ·Biochemical and Biophysical Research Communications ·Sandeep Singh, Manoj Kumar Bhat	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact